October 27, 2021

Volume XI, Number 300


Mary J. Mullany

Mary J. Mullany concentrates her practice in the areas of securities offerings, mergers and acquisitions, corporate financing (public and private), executive compensation, corporate governance, pharmaceutical and life sciences licensing and collaborations, general corporate law, business counseling, and health care law. Her client base includes large, multinational public companies; public and private middle-market companies in a variety of industries; nonprofit organizations; and start-up entities.

Mary has worked most recently on sophisticated merger and acquisition transactions for publicly traded companies, and on securities offerings including an initial public offering and secondary securities offerings. She counsels public and private companies in the areas of corporate governance, disclosure obligations, executive compensation, and financing alternatives. Much of Mary's work with pharmaceutical, biotechnology, and life science companies focuses on mergers and acquisitions, securities offerings, and other corporate financing, and on licensing agreements, including collaborations and joint ventures.

Her areas of focus include: 

  • Business and Finance
  •  Securities and Capital Markets
  • Employee Benefits and Executive Compensation
  • Health Care, 
  • Health Care Reform
  • Insurance
  • Life Sciences and Technology
  • Emerging Growth and Venture Capital
  • Mergers and Acquisitions
  • Private Equity

Articles in the National Law Review database by Mary J. Mullany